| 臺大學術典藏 |
2022-03-10T05:59:17Z |
The trans-ancestral genomic architecture of glycemic traits
|
Chen J.; Spracklen C.N.; Marenne G.; Varshney A.; Corbin L.J.; Luan J.; Willems S.M.; Wu Y.; Zhang X.; Horikoshi M.; Boutin T.S.; M?gi R.; Waage J.; Li-Gao R.; Chan K.H.K.; Yao J.; Anasanti M.D.; Chu A.Y.; Claringbould A.; Heikkinen J.; Hong J.; Hottenga J.-J.; Huo S.; Kaakinen M.A.; Louie T.; M?rz W.; Moreno-Macias H.; Ndungu A.; Nelson S.C.; Nolte I.M.; North K.E.; Raulerson C.K.; Ray D.; Rohde R.; Rybin D.; Schurmann C.; Sim X.; Southam L.; Stewart I.D.; Wang C.A.; Wang Y.; Wu P.; Zhang W.; Ahluwalia T.S.; Appel E.V.R.; Bielak L.F.; Brody J.A.; Burtt N.P.; Cabrera C.P.; Cade B.E.; Chai J.F.; Chai X.; Chang L.-C.; Chen C.-H.; Chen B.H.; Chitrala K.N.; Chiu Y.-F.; de Haan H.G.; Delgado G.E.; Demirkan A.; Duan Q.; Engmann J.; Fatumo S.A.; Gay?n J.; Giulianini F.; Gong J.H.; Gustafsson S.; Hai Y.; Hartwig F.P.; He J.; Heianza Y.; Huang T.; Huerta-Chagoya A.; Hwang M.Y.; Jensen R.A.; Kawaguchi T.; Kentistou K.A.; Kim Y.J.; Kleber M.E.; Kooner I.K.; Lai S.; Lange L.A.; Langefeld C.D.; Lauzon M.; Li M.; Ligthart S.; Liu J.; Loh M.; Long J.; Lyssenko V.; Mangino M.; Marzi C.; Montasser M.E.; Nag A.; Nakatochi M.; Noce D.; Noordam R.; Pistis G.; Preuss M.; Raffield L.; Rasmussen-Torvik L.J.; Rich S.S.; Robertson N.R.; Rueedi R.; Ryan K.; Sanna S.; Saxena R.; Schraut K.E.; Sennblad B.; Setoh K.; Smith A.V.; Spars? T.; Strawbridge R.J.; Takeuchi F.; Tan J.; Trompet S.; van den Akker E.; van der Most P.J.; Verweij N.; Vogel M.; Wang H.; Wang C.; Wang N.; Warren H.R.; Wen W.; Wilsgaard T.; Wong A.; Wood A.R.; Xie T.; Zafarmand M.H.; Zhao J.-H.; Zhao W.; Amin N.; Arzumanyan Z.; Astrup A.; Bakker S.J.L.; Baldassarre D.; Beekman M.; Bergman R.N.; Bertoni A.; Bl?her M.; Bonnycastle L.L.; Bornstein S.R.; Bowden D.W.; Cai Q.; Campbell A.; Campbell H.; Chang Y.C.; de Geus E.J.C.; Dehghan A.; Du S.; Eiriksdottir G.; Farmaki A.E.; Fr?nberg M.; Fuchsberger C.; Gao Y.; Gjesing A.P.; Goel A.; Han S.; Hartman C.A.; Herder C.; Hicks A.A.; Hsieh C.-H.; Hsueh W.A.; Ichihara S.; Igase M.; Ikram M.A.; Johnson W.C.; J?rgensen M.E.; Joshi P.K.; Kalyani R.R.; Kandeel F.R.; Katsuya T.; Khor C.C.; Kiess W.; Kolcic I.; Kuulasmaa T.; Kuusisto J.; L?ll K.; Lam K.; Lawlor D.A.; Lee N.R.; Lemaitre R.N.; Li H.; Lin S.-Y.; Lindstr?m J.; Linneberg A.; Liu J.; Lorenzo C.; Matsubara T.; Matsuda F.; Mingrone G.; Mooijaart S.; Moon S.; Nabika T.; Nadkarni G.N.; Nadler J.L.; Nelis M.; Neville M.J.; Norris J.M.; Ohyagi Y.; Peters A.; Peyser P.A.; Polasek O.; Qi Q.; Raven D.; Reilly D.F.; Reiner A.; Rivideneira F.; Roll K.; Rudan I.; Sabanayagam C.; Sandow K.; Sattar N.; Sch?rmann A.; Shi J.; Stringham H.M.; Taylor K.D.; Teslovich T.M.; Thuesen B.; Timmers P.R.H.J.; Tremoli E.; Tsai M.Y.; Uitterlinden A.; van Dam R.M.; van Heemst D.; van Hylckama Vlieg A.; van Vliet-Ostaptchouk J.V.; Vangipurapu J.; Vestergaard H.; Wang T.; Willems van Dijk K.; Zemunik T.; Abecasis G.R.; Adair L.S.; Aguilar-Salinas C.A.; Alarc?n-Riquelme M.E.; An P.; Aviles-Santa L.; Becker D.M.; Beilin L.J.; Bergmann S.; Bisgaard H.; Black C.; Boehnke M.; Boerwinkle E.; B?hm B.O.; B?nnelykke K.; Boomsma D.I.; Bottinger E.P.; Buchanan T.A.; Canouil M.; Caulfield M.J.; Chambers J.C.; Chasman D.I.; Chen Y.-D.I.; Cheng C.-Y.; Collins F.S.; Correa A.; Cucca F.; de Silva H.J.; Dedoussis G.; Elmst?hl S.; Evans M.K.; Ferrannini E.; Ferrucci L.; Florez J.C.; Franks P.W.; Frayling T.M.; Froguel P.; Gigante B.; Goodarzi M.O.; Gordon-Larsen P.; Grallert H.; Grarup N.; Grimsgaard S.; Groop L.; Gudnason V.; Guo X.; Hamsten A.; Hansen T.; Hayward C.; Heckbert S.R.; Horta B.L.; Huang W.; Ingelsson E.; James P.S.; Jarvelin M.-R.; Jonas J.B.; Jukema J.W.; Kaleebu P.; Kaplan R.; Kardia S.L.R.; Kato N.; Keinanen-Kiukaanniemi S.M.; Kim B.-J.; Kivimaki M.; Koistinen H.A.; Kooner J.S.; K?rner A.; Kovacs P.; Kuh D.; Kumari M.; Kutalik Z.; Laakso M.; Lakka T.A.; Launer L.J.; Leander K.; Li H.; Lin X.; Lind L.; Lindgren C.; Liu S.; Loos R.J.F.; Magnusson P.K.E.; Mahajan A.; Metspalu A.; Mook-Kanamori D.O.; Mori T.A.; Munroe P.B.; Nj?lstad I.; O’Connell J.R.; Oldehinkel A.J.; Ong K.K.; Padmanabhan S.; Palmer C.N.A.; Palmer N.D.; Pedersen O.; Pennell C.E.; Porteous D.J.; Pramstaller P.P.; Province M.A.; Psaty B.M.; Qi L.; Raffel L.J.; Rauramaa R.; Redline S.; Ridker P.M.; Rosendaal F.R.; Saaristo T.E.; Sandhu M.; Saramies J.; Schneiderman N.; Schwarz P.; Scott L.J.; Selvin E.; Sever P.; Shu X.-O.; Slagboom P.E.; Small K.S.; Smith B.H.; Snieder H.; Sofer T.; S?rensen T.I.A.; Spector T.D.; Stanton A.; Steves C.J.; Stumvoll M.; Sun L.; Tabara Y.; Tai E.S.; Timpson N.J.; T?njes A.; Tuomilehto J.; Tusie T.; Uusitupa M.; van der Harst P.; van Duijn C.; Vitart V.; Vollenweider P.; Vrijkotte T.G.M.; Wagenknecht L.E.; Walker M.; Wang Y.X.; Wareham N.J.; Watanabe R.M.; Watkins H.; Wei W.B.; Wickremasinghe A.R.; Willemsen G.; Wilson J.F.; Wong T.-Y.; Wu J.-Y.; Xiang A.H.; Yanek L.R.; Yengo L.; Yokota M.; Zeggini E.; Zheng W.; Zonderman A.B.; Rotter J.I.; Gloyn A.L.; McCarthy M.I.; Dupuis J.; Meigs J.B.; Scott R.A.; Prokopenko I.; Leong A.; Liu C.-T.; Parker S.C.J.; Mohlke K.L.; Langenberg C.; Wheeler E.; Morris A.P.; Barroso I.; de Haan H.G.; van den Akker E.; van der Most P.J.; de Geus E.J.C.; van Dam R.M.; van Heemst D.; van Hylckama Vlieg A.; van Willems van Dijk K.; de Silva H.J.; van der Harst P.; van Duijn C.; Lifelines Cohort Study, The Meta-Analysis of Glucose; Insulin-related Traits Consortium (MAGIC); YI-CHENG CHANG |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study
|
Su Y.-Y.; Chiu Y.-F.; Li C.-P.; SHIH-HUNG YANG; Lin J.; Lin S.-J.; Chang P.-Y.; Chiang N.-J.; Shan Y.-S.; Ch��ang H.-J.; Chen L.-T. |
| 臺大學術典藏 |
2021-11-15T08:27:58Z |
Cwc25 is a novel splicing factor required after Prp2 and Yju2 to facilitate the first catalytic reaction
|
Chiu Y.-F; Liu Y.-C; Chiang T.-W; Yeh T.-C; CHI-KANG TSENG; Wu N.-Y; Cheng S.-C. |
| 臺大學術典藏 |
2021-10-04T07:15:51Z |
Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine
|
JEN-CHANG KO; Tsai M.-S.; Kuo Y.-H.; Chiu Y.-F.; Weng S.-H.; Su Y.-C.; Lin Y.-W. |
| 臺大學術典藏 |
2021-10-04T07:15:51Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. |
| 臺大學術典藏 |
2021-10-04T07:15:50Z |
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells
|
JEN-CHANG KO; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-10-04T07:15:50Z |
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells
|
JEN-CHANG KO; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W. |
| 臺大學術典藏 |
2021-10-04T07:15:34Z |
Cross-talk between SOX2 and TGFb signaling regulates EGFR-TKI tolerance and lung cancer dissemination
|
Kuo M.-H.; Lee A.-C.; Hsiao S.-H.; Lin S.-E.; Chiu Y.-F.; Yang L.-H.; Yu C.-C.; Chiou S.-H.; Huang H.-N.; JEN-CHANG KO; Chou Y.-T. |
| 臺大學術典藏 |
2021-09-01T01:54:05Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 臺大學術典藏 |
2021-07-28T09:53:19Z |
Cwc25 is a novel splicing factor required after Prp2 and Yju2 to facilitate the first catalytic reaction
|
Chiu Y.-F; | Liu Y.-C; | Chiang T.-W; | Yeh T.-C; | CHI-KANG TSENG; | Wu N.-Y; | Cheng S.-C. |
| 臺大學術典藏 |
2021-04-29T05:09:10Z |
Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia
|
Hosgood III H.D.; Wang W.-C.; Hong Y.-C.; Wang J.-C.; Chen K.; Chang I.-S.; Chen C.-J.; Lu D.; Yin Z.; Wu C.; Zheng W.; Qian B.; Park J.Y.; Kim Y.H.; Chatterjee N.; Chen Y.; Chang G.-C.; Hsiao C.-F.; Yeager M.; Tsai Y.-H.; Wei H.; Kim Y.T.; Wu W.; Zhao Z.; Chow W.-H.; Zhu X.; Lo Y.-L.; Sung S.W.; KUAN-YU CHEN; Yuenger J.; Kim J.H.; Huang L.; Chen Y.-H.; Gao Y.-T.; Kim J.H.; Huang M.-S.; Jung T.H.; Caporaso N.; Zhao X.; Huan Z.; Yu D.; Kim C.H.; Su W.-C.; Shu X.-O.; Kim I.-S.; Bassig B.; Chen Y.-M.; Cha S.I.; Tan W.; Chen H.; Yang T.-Y.; Sung J.S.; Wang C.-L.; Li X.; Park K.H.; Yu C.-J.; Ryu J.-S.; Xiang Y.; Hutchinson A.; Kim J.S.; Cai Q.; Landi M.T.; Lee K.-M.; Hung J.-Y.; Park J.-Y.; Tucker M.; Lin C.-C.; Ren Y.; Perng R.-P.; Chen C.-Y.; Jin L.; Chen K.-C.; Li Y.-J.; Chiu Y.-F.; Tsai F.-Y.; Yang P.-C.; Fraumeni Jr. J.F.; Seow A.; Lin D.; Zhou B.; Chanock S.; Hsiung C.A.; Rothman N.; Lan Q. |
| 臺大學術典藏 |
2021-03-11T08:34:28Z |
Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine
|
Jen-Chang Ko ;Tsai M.-S. ;Kuo Y.-H. ;Chiu Y.-F. ;Weng S.-H. ;Su Y.-C. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Kuo Y.-H.; Chiu Y.-F.; Weng S.-H.; Su Y.-C.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:28Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:27Z |
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells
|
Jen-Chang Ko;Tsai M.-S.;Weng S.-H.;Kuo Y.-H.;Chiu Y.-F.;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:27Z |
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells
|
Jen-Chang Ko;Tsai M.-S.;Chiu Y.-F.;Weng S.-H.;Kuo Y.-H.;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:15Z |
Cross-talk between SOX2 and TGFb signaling regulates EGFR-TKI tolerance and lung cancer dissemination
|
Kuo M.-H.; Lee A.-C.; Hsiao S.-H.; Lin S.-E.; Chiu Y.-F.; Yang L.-H.; Yu C.-C.; Chiou S.-H.; Huang H.-N.; JEN-CHANG KO; Chou Y.-T. |
| 臺大學術典藏 |
2021-03-11T08:29:41Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:40Z |
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells
|
Jen-Chang Ko ;Tsai M.-S. ;Weng S.-H. ;Kuo Y.-H. ;Chiu Y.-F. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:40Z |
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells
|
Jen-Chang Ko ;Tsai M.-S. ;Chiu Y.-F. ;Weng S.-H. ;Kuo Y.-H. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:40Z |
Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine
|
Jen-Chang Ko ;Tsai M.-S. ;Kuo Y.-H. ;Chiu Y.-F. ;Weng S.-H. ;Su Y.-C. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Kuo Y.-H.; Chiu Y.-F.; Weng S.-H.; Su Y.-C.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:29Z |
Cross-talk between SOX2 and TGFb signaling regulates EGFR-TKI tolerance and lung cancer dissemination
|
Kuo M.-H.; Lee A.-C.; Hsiao S.-H.; Lin S.-E.; Chiu Y.-F.; Yang L.-H.; Yu C.-C.; Chiou S.-H.; Huang H.-N.; JEN-CHANG KO; Chou Y.-T. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine
|
Jen-Chang Ko;Tsai M.-S.;Kuo Y.-H.;Chiu Y.-F.;Weng S.-H.;Su Y.-C.;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Kuo Y.-H.; Chiu Y.-F.; Weng S.-H.; Su Y.-C.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells
|
Jen-Chang Ko ;Tsai M.-S. ;Chiu Y.-F. ;Weng S.-H. ;Kuo Y.-H. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:35Z |
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells
|
Jen-Chang Ko ;Tsai M.-S. ;Weng S.-H. ;Kuo Y.-H. ;Chiu Y.-F. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W. |
